Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

7 projects found matching your search criteria :

  1. Role of CacyBP/SIP in the dysregulation of beta-catenin ubiquitination in YAC128 mouse model of Huntington's disease

    Call: SONATA 8 , Panel: NZ3

    Principal investigator: dr Magdalena Czeredys

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  2. The role of acquired channelopathies in facilitationg post-traumatic epileptogenesis in APP/PS1 transgenic mice - an ani...

    Call: PRELUDIUM 3 , Panel: NZ4

    Principal investigator: Diana Miszczuk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  3. PrP amyloid as a model amyloid formation in transgenic mice, in chronic wasting disease - a novel prion disease

    Call: HARMONIA 2 , Panel: NZ4

    Principal investigator: prof. Paweł Liberski

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski z Oddziałem Stomatologicznym

  4. Involvement of astrocytes in the neuroprotective mechanism evoked by enhancement of noradrenergic transmission in trasng...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Justyna Barut

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  5. Transgenic mice with elevated basal level of calcium ions in neurons as a model of aged-induced neurodegeneration of spo...

    Call: MAESTRO 1 , Panel: NZ3

    Principal investigator: prof. Jacek Kuźnicki

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  6. Linking abnormal Ca2+ signaling and the unfolded protein response with Huntington's disease pathology in both YAC128 mou...

    Call: OPUS 17 , Panel: NZ3

    Principal investigator: dr Magdalena Czeredys

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

  7. Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: dr Grzegorz Kreiner

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk